Abstract
Conflicts of interest: call for new editorial policies in European national journals
Highlights
During the past decade, disclosure of conflicts of interest (COIs) has been considered the key to ensure the credibility of the scientific process [1, 2]
For the two journals disclosing data, income from the sales of reprints contributed to 3 % and 41 % of the total income for BMJ and The Lancet in 2005–2006 (NEJM and JAMA did not respond!)
It was suggested that journals disclose financial information in the same way that they require it from their authors, so that readers can assess the potential effect of different types of papers on journals’ revenue and impact
Summary
Disclosure of conflicts of interest (COIs) has been considered the key to ensure the credibility of the scientific process [1, 2]. JAMA, The Lancet, and New England Journal of Medicine [NEJM]) in order to investigate industry-supported trials’ influence on journal impact factors and revenue. The proportion of trials with sole industry support varied between journals from 7 % in BMJ to 32 % in NEJM in 2005–2006.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
